FDA Issues Warning Letter to Louisville Reproductive Center
February 11, 2026
February 11, 2026
WASHINGTON, Feb. 11 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Louisville Reproductive Center from the Center for Biologics Evaluation and Research:
* * *
Recipient: Dr. Miriam S. Krause, Medical Director, Louisville Reproductive Center, 4123 Dutchmans Lane, Suite 416, Louisville, KY 40207-4733, United States, Mkrause@ivfkentucky.com
Issuing Office: Center for Biologics Evaluation . . .
* * *
Recipient: Dr. Miriam S. Krause, Medical Director, Louisville Reproductive Center, 4123 Dutchmans Lane, Suite 416, Louisville, KY 40207-4733, United States, Mkrause@ivfkentucky.com
Issuing Office: Center for Biologics Evaluation . . .